➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
McKesson
Harvard Business School
AstraZeneca
Baxter
Boehringer Ingelheim

Last Updated: July 12, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Phenylacetic acid


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the drug development status for Phenylacetic acid?

Phenylacetic acid is an investigational drug.

There have been 4 clinical trials for Phenylacetic acid. The most recent clinical trial was a Phase 1 trial, which was initiated on November 1st 2017.

The most common disease conditions in clinical trials are Urea Cycle Disorders, Inborn, Disease, and Drug-Related Side Effects and Adverse Reactions. The leading clinical trial sponsors are Shijiazhuang Yiling Pharmaceutical Co. Ltd, Horizon Therapeutics, LLC, and Yiling Pharmaceutical Inc.

There are three US patents protecting this investigational drug and forty-three international patents.

Recent Clinical Trials for Phenylacetic acid
TitleSponsorPhase
A Phase I Clinical Study Trial of Felbinac Trometamol Injection in ChinaShijiazhuang Yiling Pharmaceutical Co. LtdPhase 1
Study of Glycerol Phenylbutyrate & Sodium Phenylbutyrate in Phenylbutyrate Naïve Patients With Urea Cycle DisordersHorizon Therapeutics, LLCPhase 4
A Phase I Clinical Study Trial of Felbinac Trometamol Injection in ChinaYiling Pharmaceutical Inc.Phase 1

See all Phenylacetic acid clinical trials

Clinical Trial Summary for Phenylacetic acid

Top disease conditions for Phenylacetic acid
Top clinical trial sponsors for Phenylacetic acid

See all Phenylacetic acid clinical trials

US Patents for Phenylacetic acid

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Phenylacetic acid   Start Trial Compounds for the treatment of infectious diseases Hoffmann-La Roche Inc. (Little Falls, NJ)   Start Trial
Phenylacetic acid   Start Trial 4-hydroxy-3-(heteroaryl)pyridine-2-one APJ agonists Bristol-Myers Squibb Company (Princeton, NJ)   Start Trial
Phenylacetic acid   Start Trial Compositions containing polymeric, ionic compounds comprising imidazolium groups BASF SE (Ludwigshafen, DE)   Start Trial
Phenylacetic acid   Start Trial Uracil derivatives as AXL and c-MET kinase inhibitors IGNYTA, INC. (San Diego, CA)   Start Trial
Phenylacetic acid   Start Trial Pyrrolidine amide compounds as histone demethylase inhibitors GENENTECH, INC. (South San Francisco, CA) CONSTELLATION PHARMACEUTICALS INC. (Cambridge, MA)   Start Trial
Phenylacetic acid   Start Trial Production of organic materials using oxidative hydrothermal dissolution method SOUTHERN ILLINOIS UNIVERSITY CARBONDALE (Carbondale, IL)   Start Trial
Phenylacetic acid   Start Trial Therapeutic inhibitory compounds LIFESCI PHARMACEUTICALS, INC. (St. Michael, BB)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Phenylacetic acid

Drugname Country Document Number Estimated Expiration Related US Patent
Phenylacetic acid China 107001386 2034-10-11   Start Trial
Phenylacetic acid European Patent Office 3204392 2034-10-11   Start Trial
Phenylacetic acid Japan 2017531655 2034-10-11   Start Trial
Phenylacetic acid World Intellectual Property Organization (WIPO) 2016055553 2034-10-11   Start Trial
Phenylacetic acid Argentina 104884 2035-06-03   Start Trial
Phenylacetic acid Australia 2016270903 2035-06-03   Start Trial
Phenylacetic acid Brazil 112017024846 2035-06-03   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
AstraZeneca
Boehringer Ingelheim
Colorcon
Medtronic
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.